These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 655537)

  • 1. Route of absorption of drug and ointment after application to the eye.
    Scruggs J; Wallace T; Hanna C
    Ann Ophthalmol; 1978 Mar; 10(3):267-71. PubMed ID: 655537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of drug vehicle on ocular contact time of sulfacetamide sodium.
    Hanna C; Hof WC; Smith WG
    Ann Ophthalmol; 1985 Sep; 17(9):560-4. PubMed ID: 3904569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.
    Lee YH; Kompella UB; Lee VH
    Exp Eye Res; 1993 Sep; 57(3):341-9. PubMed ID: 7901046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of releasing rate of pilocarpine hydrochloride from hydrogel eye ointments].
    Kecik T; Szlaski J; Portacha L; Lewandowski P; Marchlewska B; Pacak I
    Klin Oczna; 1993 Jul; 95(7):263-4. PubMed ID: 8121144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of chlortetracycline hydrochloride and chloramphenicol in some ophthalmic ointment bases.
    Attia MA; el-Sourady HA; el-Shanawany SM
    Pharmazie; 1985 Sep; 40(9):629-31. PubMed ID: 4070345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "bubble point" for validation of drug release or simulated absorption tests for ointments.
    Realdon N; Tagliaboschi A; Perin F; Ragazzi E
    Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioavailability of drugs applied to the eye externally].
    Sieradzki E
    Klin Oczna; 1991 Jan; 93(1):34-6. PubMed ID: 2046287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of drugs in ointment for routine mydriasis.
    Hendrickson RO; Hanna C
    Ann Ophthalmol; 1977 Mar; 9(3):333-6. PubMed ID: 869415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic ointments.
    Robin JS; Ellis PP
    Surv Ophthalmol; 1978; 22(5):335-40. PubMed ID: 653578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drug vehicles on ocular uptake of tetracycline.
    Hardberger RE; Hanna C; Goodart R
    Am J Ophthalmol; 1975 Jul; 80(1):133-8. PubMed ID: 1155539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of retention and drug-release of ophthalmic ointment on the ocular surface].
    Takaoka M; Yokoi N; Ishibashi T; Kinoshita S
    Nippon Ganka Gakkai Zasshi; 2004 May; 108(5):307-11. PubMed ID: 15188605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular penetration of chloramphenicol. Effects of route of administration.
    George FJ; Hanna C
    Arch Ophthalmol; 1977 May; 95(5):879-82. PubMed ID: 558746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rheological studies and biopharmaceutical evaluation of ointments containing selected antibiotics. II. Effect of the ointment base on rheological properties and the rate of liberation and absorption of chloramphenicol].
    Zakrzewski Z; Hudemowicz W
    Acta Pol Pharm; 1981; 38(1):99-105. PubMed ID: 7315463
    [No Abstract]   [Full Text] [Related]  

  • 14. Review: systemic absorption of topically applied ocular drugs in humans.
    Salminen L
    J Ocul Pharmacol; 1990; 6(3):243-9. PubMed ID: 2290070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of the eye. Proctor lecture.
    Mishima S
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):504-41. PubMed ID: 6116682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of drug vehicle on human ocular retention of topically applied tetracycline.
    Massey JY; Hanna C; Goodart R; Wallace T
    Am J Ophthalmol; 1976 Feb; 81(2):151-6. PubMed ID: 766637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of drug vehicles on ocular contact time.
    Hardberger R; Hanna C; Boyd CM
    Arch Ophthalmol; 1975 Jan; 93(1):42-5. PubMed ID: 1111487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Penetration kinetics of fluocortolone from a new base for ointment and creme (author's transl)].
    Flasch H; Hofferber E
    Arzneimittelforschung; 1980; 30(4):652-6. PubMed ID: 7190408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
    Ahmed I; Patton TF
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):584-7. PubMed ID: 3884542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic toxicity. Associated with topical ophthalmic medications.
    Flach AJ
    J Fla Med Assoc; 1994 Apr; 81(4):256-60. PubMed ID: 8046365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.